학술논문
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer
Document Type
Article
Author
Mayer, E.L.; Wagle, N.; Sinclair, N.; Faggen, M.; Block, C.C.; Partridge, A.H.; Chen, W.Y.; Demeo, M.; Attaya, V.; Okpoebo, A.; Alberti, J.; Burstein, H.J.; Tolaney, S.M.; Regan, M.M.; Ren, Y.; Mahtani, R.; Ma, C.; Demichele, A.; Cristofanilli, M.; Meisel, J.; Miller, K.D.; Abdou, Y.; Riley, E.C.; Qamar, R.; Sharma, P.; Reid, S.; Ko, N.; Liu, Y.; Gauthier, E.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 10 June 2024, 42(17):2050-2060)
Subject
Language
English
ISSN
15277755
0732183X
0732183X